Loading...

Equasens S.A.

0R9T.L•LSE
Healthcare
Medical - Equipment & Services
£48.10
£0.10(0.21%)

Equasens S.A. (0R9T.L) Stock Overview

Explore Equasens S.A.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 75.6/100

Key Financials

Market Cap723M
P/E Ratio20.89
EPS (TTM)$2.58
ROE0.16%
Fundamental Analysis

AI Price Forecasts

1 Week$51.37
1 Month$34.94
3 Months$37.49
1 Year Target$35.64

0R9T.L Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Equasens S.A. (0R9T.L) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 43.75, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $35.64.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 20.89 and a market capitalization of 723M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;